Biotech Values

[BTH]

$CYTK

This relates directly to tirasemtiv:

Profound unmet medical needs remain for patients with ALS. Patients need new
treatments to provide symptomatic relief, and to slow, halt, reverse, or prevent ALS. In addition
to fulfilling responsibilities to regulate clinical testing and marketing of new treatments for ALS,
FDA facilitates the work of researchers and medical product manufacturers by providing expert
technical assistance.
The purpose of this meeting is for FDA to hear from stakeholders regarding the needs
and preferences of patients, as well as suggestions regarding how best to be responsive to those
needs and preferences.

http://www.ofr.gov/(X(1)S(fkvovmw4engmxfrpaowrbopr))/OFRUpload/OFRData/2013-02088_PI.pdf